Hiszpania - hiszpański - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

novartis farmaceutica s.a. - tobramicina - colirio en soluciÓn - 3 mg/ml - tobramicina 3 mg - tobramicina

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - tobramycin 3 mg/ml - eye drops, solution - 0.3 % - active: tobramycin 3 mg/ml excipient: benzalkonium chloride boric acid purified water sodium chloride sodium hydroxide sodium sulfate sulfuric acid tyloxapol - tobrex eye drops and eye ointment are topical antibiotics indicated in the treatment of external infections of the eye and its adnexa caused by susceptible bacteria. appropriate monitoring of bacterial response to topical antibiotic therapy should accompany the use of tobrex.

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - tobramycin 0.3%{relative};   - eye ointment - 0.3 % - active: tobramycin 0.3%{relative}   excipient: chlorobutanol liquid paraffin white soft paraffin - tobrex eye ointment is indicated for the treatment of external infections of the eye and its adnexa caused by susceptible bacteria. appropriate monitoring of bacterial response to topical antibiotic therapy should accompany the use of tobrex.

Rumunia - rumuński - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

alcon couvreur nv - belgia - tobramycinum - pic. oft., sol. - 3mg/ml - antiinfectioase antibiotice

Rumunia - rumuński - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

alcon-couvreur n.v. - belgia - tobramycinum - ung. oft. - 3mg/g - antiinfectioase antibiotice

Rumunia - rumuński - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

alcon cusi s.a. - spania - tobramycinum - picaturi oft., sol. - 3mg/ml - antiinfectioase antibiotice

Francja - francuski - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

novartis pharma sas - tobramycine 0 - collyre - 0,300 g - pour 100 ml de collyre > tobramycine 0,300 g - antibiotiques ophtalmologiques - classe pharmacothérapeutique : antibiotiques ophtalmiques - code atc : s01aa12.ce médicament contient un antibiotique de la famille des aminosides : la tobramycine.ce médicament est indiqué dans le traitement local de certaines infections de l'œil dues à des bactéries pouvant être combattues par cet antibiotique, chez l’adulte et l’enfant de plus de 1 an : conjonctivites, kératites (inflammation de la cornée d'origine bactérienne) et ulcères de la cornée.

Brazylia - portugalski - ANVISA (Agência Nacional de Vigilância Sanitária)

novartis biociencias s.a - tobramicina - antinfecciosos topicos para uso oftalmico

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

rebel distributors corp - tobramycin (unii: vz8rrz51vk) (tobramycin - unii:vz8rrz51vk) - tobramycin 3 mg in 1 g - tobrex (tobramycin ophthalmic ointment) 0.3 % is a topical antibiotic indicated in the treatment of external infections of the eye and its adnexa caused by susceptible bacteria. appropriate monitoring of bacterial response to topical antibiotic therapy should accompany the use of tobrex (tobramycin ophthalmic ointment) 0.3%. clinical studies have shown tobramycin to be safe and effective for use in children. tobrex (tobramycin ophthalmic ointment) 0.3% is contraindicated in patients with known hypersensitivity to any of its components.

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

stat rx llc usa - tobramycin (unii: vz8rrz51vk) (tobramycin - unii:vz8rrz51vk) - tobramycin 3 mg in 1 g - tobrex (tobramycin ophthalmic ointment) 0.3 % is a topical antibiotic indicated in the treatment of external infections of the eye and its adnexa caused by susceptible bacteria. appropriate monitoring of bacterial response to topical antibiotic therapy should accompany the use of tobrex (tobramycin ophthalmic ointment) 0.3%. clinical studies have shown tobramycin to be safe and effective for use in children. tobrex (tobramycin ophthalmic ointment) 0.3% is contraindicated in patients with known hypersensitivity to any of its components.